Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Prevalence and correlates of current daily use of electronic cigarettes in the European Union: analysis of the 2014 Eurobarometer survey.

Farsalinos KE, Poulas K, Voudris V, Le Houezec J.

Intern Emerg Med. 2017 Sep;12(6):757-763. doi: 10.1007/s11739-017-1643-7. Epub 2017 Mar 4.

PMID:
28260221
2.

Electronic cigarette experimentation in the Malaysian city of Kuantan: Was there an association with the smoking status?

Farsalinos KE, Le Houezec J.

J Pharm Bioallied Sci. 2016 Oct-Dec;8(4):347-348. doi: 10.4103/0975-7406.199341. No abstract available.

3.

E-cigarette use in the European Union: millions of smokers claim e-cigarettes helped them quit.

Farsalinos KE, Poulas K, Voudris V, Le Houezec J.

Addiction. 2017 Mar;112(3):545-546. doi: 10.1111/add.13722. No abstract available.

PMID:
28168790
4.

Electronic cigarette use in the European Union: analysis of a representative sample of 27‚ÄČ460 Europeans from 28 countries.

Farsalinos KE, Poulas K, Voudris V, Le Houezec J.

Addiction. 2016 Nov;111(11):2032-2040. doi: 10.1111/add.13506. Epub 2016 Aug 21.

PMID:
27338716
5.

Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes).

Farsalinos KE, Le Houezec J.

Risk Manag Healthc Policy. 2015 Sep 29;8:157-67. doi: 10.2147/RMHP.S62116. eCollection 2015. Review.

6.

Quit and smoking reduction rates in vape shop consumers: a prospective 12-month survey.

Polosa R, Caponnetto P, Cibella F, Le-Houezec J.

Int J Environ Res Public Health. 2015 Mar 24;12(4):3428-38. doi: 10.3390/ijerph120403428.

7.

Risks of attempting to regulate nicotine flux in electronic cigarettes.

Farsalinos KE, Voudris V, Le Houezec J.

Nicotine Tob Res. 2015 Feb;17(2):163-4. doi: 10.1093/ntr/ntu207. Epub 2014 Oct 19. No abstract available.

8.

A critique of a World Health Organization-commissioned report and associated paper on electronic cigarettes.

McNeill A, Etter JF, Farsalinos K, Hajek P, le Houezec J, McRobbie H.

Addiction. 2014 Dec;109(12):2128-34. doi: 10.1111/add.12730. Epub 2014 Oct 20.

PMID:
25196419
9.

Comment on "E-cigarettes and cardiovascular risk: beyond science and mysticism".

Farsalinos KE, Romagna G, Le Houezec J.

Semin Thromb Hemost. 2014 Jun;40(4):517-8. doi: 10.1055/s-0034-1375702. Epub 2014 May 6. No abstract available.

PMID:
24802086
10.

Should e-cigarettes be regulated as a medicinal device?

Hajek P, Foulds J, Le Houezec J, Sweanor D, Yach D.

Lancet Respir Med. 2013 Aug;1(6):429-31. doi: 10.1016/S2213-2600(13)70124-3. Epub 2013 Jul 23. No abstract available.

PMID:
24429230
11.

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

Le Houezec J, Aubin HJ.

Expert Opin Pharmacother. 2013 Oct;14(14):1959-67. doi: 10.1517/14656566.2013.818978. Epub 2013 Aug 26. Review.

PMID:
23978314
12.

Tobacco, nicotine and harm reduction.

Le Houezec J, McNeill A, Britton J.

Drug Alcohol Rev. 2011 Mar;30(2):119-23. doi: 10.1111/j.1465-3362.2010.00264.x. Review.

PMID:
21375611
13.

Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler.

Kralikova E, Kozak JT, Rasmussen T, Gustavsson G, Le Houezec J.

BMC Public Health. 2009 Nov 27;9:433. doi: 10.1186/1471-2458-9-433.

14.

Testing the Cigarette Dependence Scale in 4 samples of daily smokers: psychiatric clinics, smoking cessation clinics, a smoking cessation website and in the general population.

Etter JF, Le Houezec J, Huguelet P, Etter M.

Addict Behav. 2009 May;34(5):446-50. doi: 10.1016/j.addbeh.2008.12.002. Epub 2008 Dec 24.

PMID:
19157716
15.

Time for a tobacco and nicotine regulatory authority for France.

Le Houezec J, Hirsch A, Martinet Y.

Tob Control. 2006 Aug;15(4):343-4. No abstract available.

16.

Smoking habits, nicotine use, and congenital malformations.

Le Houezec J, Benowitz NL.

Obstet Gynecol. 2006 May;107(5):1166; author reply 1168. No abstract available. Erratum in: Obstet Gynecol. 2006 Jul;108(1):215.

PMID:
16648425
17.

Why a nicotine vaccine?

Le Houezec J.

Clin Pharmacol Ther. 2005 Nov;78(5):453-5. No abstract available.

PMID:
16321611
18.

France: smoking in pregnancy consensus conference.

Le Houezec J.

Tob Control. 2005 Jun;14(3):149-50. No abstract available.

19.
20.

A self-administered questionnaire to measure dependence on cigarettes: the cigarette dependence scale.

Etter JF, Le Houezec J, Perneger TV.

Neuropsychopharmacology. 2003 Feb;28(2):359-70.

Supplemental Content

Loading ...
Support Center